Scientists identify new pathogenic and protective microbes associated with severe diarrhea

June 27, 2014
Mihai Pop, an associate professor of computer science at the University of Maryland, recently concluded a major study of diarrheal pathogens in young children from low-income countries. Credit: University of Maryland

In a finding that may one day help control a major cause of death among children in developing countries, a team of researchers led by faculty from the University of Maryland, College Park and the University of Maryland School of Medicine has identified microorganisms that may trigger diarrheal disease and others that may protect against it. These microbes were not widely linked to the condition previously.

"We were able to identify interactions between microbiota that were not previously observed, and we think that some of those interactions may actually help prevent the onset of severe diarrhea," says O. Colin Stine, a professor of epidemiology and public health at the University of Maryland School of Medicine.

A much better understanding of these interactions is important, Stine adds, as they could lead to possible dietary interventions. Moderate to severe diarrhea (MSD) is a major cause of in developing countries and ranks as one of the top four causes of death among young children in sub-Saharan Africa and South Asia.

Stine and Mihai Pop, an associate professor of computer science at the University of Maryland, College Park led the six-year project funded by $10.1 million from the Bill & Melinda Gates Foundation. The research results are available in a paper published today in the journal Genome Biology.

The researchers used a technique called high-throughput 16S rRNA genomic sequencing to examine both "good" and "bad" microbiota—the tens of trillions of microbes that inhabit the human intestinal system—in samples taken from 992 children in Bangladesh, The Gambia, Kenya and Mali under the age of 5 who were suffering from MSD.

The researchers identified statistically significant disease associations with several organisms already implicated in , such as members of the Escherichia/Shigella genus and Campylobacter jejuni. They also found that organisms not widely believed to cause the disease, including Streptococcus and Granulicatella, correlated with the condition in their study. In addition, the study revealed that the Prevotella genus and Lactobacillus ruminis may play a protective role against diarrhea.

The project is an offshoot of a $20 million study commissioned by the Gates Foundation in 2006. The Global Enterics Multicenter Study (GEMS) was launched in response to unanswered questions surrounding the burden and etiology of childhood diarrhea in developing countries.

GEMS collected troves of useful data on MSD, yet there were still some uncertainties, says Pop, who also has an appointment in the University of Maryland Institute for Advanced Computer Studies.

For example, in almost 50 percent of the children examined with diarrhea, the condition could not be attributed to a specific causal pathogen. The GEMS research also found numerous children carrying Shigella, which is known to cause problems, yet the children showed no signs of MSD.

The Gates Foundation contacted the two University of Maryland scientists in 2007, looking for new analyses of the GEMS data via a combination of computational biology, epidemiology and .

"New technologies have opened up new windows of discovery, so they asked us to look at the samples," says Pop, who adds that he and Stine expect to conduct further genomic and epidemiological studies to assess the potential development of diet- or microbiological-based therapeutics.

The longstanding scientific collaboration between the two researchers is enhanced by the MPowering the State strategic partnership, launched in 2011 to support collaborative research and education between the state's top two public research institutions, the University of Maryland, College Park and the University of Maryland, Baltimore.

Explore further: A handful of pathogens are causing most diarrhoeal deaths and illness in children worldwide and should be targeted

Related Stories

A handful of pathogens are causing most diarrhoeal deaths and illness in children worldwide and should be targeted

May 13, 2013
New research in The Lancet reports that just four pathogens—rotavirus, Cryptosporidium, enterotoxigenic Escherichia coli producing heat-stable toxin, and Shigella—are causing most cases of moderate-to-severe diarrhoea ...

Risk factors for death identified for children with diarrhea in rural Kenya

July 3, 2012
A hospital-based surveillance study conducted by Ciara O'Reilly of the Centers for Disease Control and Prevention, Atlanta, Georgia, USA and colleagues describes the risk factors for death amongst children who have been hospitalized ...

Researchers find two distinct strains in 2010 Haitian cholera outbreak

June 18, 2012
A new study by an international team of scientists led by researchers from the Institute for Genome Sciences (IGS) at the University of Maryland School of Medicine, the Center for Bioinformatics and Computational Biology ...

Vaccine for infant tummy bug cuts hospitalizations: CDC

June 9, 2014
(HealthDay)—Since the introduction of rotavirus vaccine in 2006, the number of kids hospitalized for severe diarrhea has dropped dramatically, a new study finds.

Deadly diarrhea caused by wastewater on crops

March 4, 2014
Researchers have identified that the use of wastewater to irrigate vegetable crops, which is common across developing countries, may significantly contribute to deadly health risks such as rotavirus, a major cause of diarrheal ...

India announces low-cost rotavirus vaccine (Update)

May 14, 2013
The Indian government announced Tuesday the development of a new low-cost vaccine proven effective against a diarrhea-causing virus that is one of the leading causes of childhood deaths across the developing world.

Recommended for you

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.